American Century Companies’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,368
Closed -$96.2K 2896
2026
Q1
$96.2K Sell
11,368
-674,216
-98% -$7.38M ﹤0.01% 2782
2025
Q4
$7.74M Buy
685,584
+19,666
+3% +$244K ﹤0.01% 1561
2025
Q3
$10M Buy
665,918
+4,637
+0.7% +$67.5K 0.01% 1425
2025
Q2
$9.33M Buy
661,281
+94,780
+17% +$1.69M 0.01% 1403
2025
Q1
$13.6M Buy
566,501
+7,740
+1% +$273K 0.01% 1202
2024
Q4
$20.9M Buy
558,761
+48,286
+9% +$2.25M 0.01% 1021
2024
Q3
$25.5M Sell
510,475
-762
-0.1% -$29.6K 0.01% 917
2024
Q2
$17.7M Buy
511,237
+319,634
+167% +$12.6M 0.01% 1018
2024
Q1
$10.5M Sell
191,603
-143,395
-43% -$7.1M 0.01% 1185
2023
Q4
$14.3M Sell
334,998
-175,237
-34% -$5.45M 0.01% 994
2023
Q3
$13.3M Buy
510,235
+60,689
+14% +$1.26M 0.01% 968
2023
Q2
$10.8M Buy
449,546
+34,596
+8% +$596K 0.01% 1026
2023
Q1
$5.66M Sell
414,950
-1,142
-0.3% -$18.2K ﹤0.01% 1219
2022
Q4
$5.78M Buy
+416,092
New +$5.88M ﹤0.01% 1173

Other funds holding BHVN

American Century Companies's BHVN Position: Q2 2026 in Review

American Century Companies sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 11,368 shares — an estimated $96.2K sold.

American Century Companies first reported a position in BHVN in Q4 2022 and held it in 14 quarters. The position peaked at $25.5M in Q3 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • American Century Companies reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • American Century Companies sold 11,368 Biohaven shares in Q2 2026, an estimated $96.2K.
  • American Century Companies first reported a position in Biohaven in Q4 2022 and held it in 14 quarters.
  • American Century Companies's Biohaven position peaked at $25.5M in Q3 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.